Abstract: “Object” To provide a tilt-imparted liquid crystal display element that is obtained through UV irradiation of a polymerizable liquid crystal composition, whose drive voltage can be reduced with a fast decay time maintained, and that is well balanced between characteristics, such as decay time, drive voltage, and transmittance. A polymerizable liquid crystal composition for use in it is also provided. “Solution” A liquid crystal display element has polymer networks formed in the liquid crystal phase 5 in FIG. 3. The polymer networks are formed by polymerizing a polymerizable liquid crystal composition that contains, as essential ingredients, a radically polymerizable monomer component (A), a liquid crystal material (B), and a polymerization initiator (C) that has a molecular structure resulting from substituting any two or more hydrogen atoms in the aromatic nucleus in the molecular structure of an alkylphenone-based photopolymerization initiator, for example with a C1-10 alkyl group (i).

Abstract: Provided are a compound represented by general formula (I), a liquid crystal composition that uses the compound, and a liquid crystal display device that uses the liquid crystal composition. Adding the compound represented by general formula (I) to a liquid crystal composition can prevent degradation of the liquid crystal composition by light, heat, etc. The compound represented by general formula (I) dissolves well in the liquid crystal composition. Thus, when the compound represented by general formula (I) is used, a liquid crystal composition having both low viscosity (?) and high reliability can be prepared, and a high-speed response liquid crystal display device can be provided.

Abstract: Provided are a compound represented by general formula (I), a liquid crystal composition that uses the compound, and a liquid crystal display device that uses the liquid crystal composition. Adding the compound represented by general formula (I) to a liquid crystal composition can prevent degradation of the liquid crystal composition by light, heat, etc. The compound represented by general formula (I) dissolves well in the liquid crystal composition. Thus, when the compound represented by general formula (I) is used, a liquid crystal composition having both low viscosity (?) and high reliability can be prepared, and a high-speed response liquid crystal display device can be provided.

Abstract: Provided is a liquid crystal alignment layer of which a constituent member is a compound represented by the general formula (I).

Abstract: An object of the invention is to provide a polymerizable compound having small refractive index anisotropy and having high storage stability and high alignment properties when constituting a polymerizable liquid crystal composition, and provide a polymerizable liquid crystal composition containing the polymerizable compound. Further, the object is to provide a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer. The present invention provides a polymerizable compound represented by general formula (I), a polymerizable liquid crystal composition containing the compound as a constituent component, and further provides a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer.

Abstract: Provided is a liquid crystal alignment layer of which a constituent member is a polymer represented by the general formula (I).

Abstract: An object of the invention is to provide a polymerizable compound having small refractive index anisotropy and having high storage stability and high alignment properties when constituting a polymerizable liquid crystal composition, and provide a polymerizable liquid crystal composition containing the polymerizable compound. Further, the object is to provide a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer. The present invention provides a polymerizable compound represented by general formula (I), a polymerizable liquid crystal composition containing the compound as a constituent component, and further provides a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer.

Abstract: An object of the invention is to provide a polymerizable compound having small refractive index anisotropy and having high storage stability and high alignment properties when constituting a polymerizable liquid crystal composition, and provide a polymerizable liquid crystal composition containing the polymerizable compound. Further, the object is to provide a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer. The present invention provides a polymerizable compound represented by general formula (I), a polymerizable liquid crystal composition containing the compound as a constituent component, and further provides a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer.

Abstract: Provided is a liquid crystal alignment layer of which a constituent member is a polymer represented by the general formula (I).

Abstract: Provided is a liquid crystal alignment layer of which a constituent member is a compound represented by the general formula (I).

Abstract: An object of the invention is to provide a polymerizable compound having small refractive index anisotropy and having high storage stability and high alignment properties when constituting a polymerizable liquid crystal composition, and provide a polymerizable liquid crystal composition containing the polymerizable compound. Further, the object is to provide a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer. The present invention provides a polymerizable compound represented by general formula (I), a polymerizable liquid crystal composition containing the compound as a constituent component, and further provides a polymer produced by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body including the polymer.

Abstract: The present invention provides a liquid crystal composition having a negative dielectric anisotropy whose absolute value is large, and a low viscosity, and also provides a VA type liquid crystal element using the same. Disclosed is a liquid crystal composition containing a compound represented by the general formula (I) and an alkenyl compound represented by the general formula (II): By combining the liquid compounds according to the present invention, a liquid crystal composition having a low viscosity and a negative dielectric anisotropy could be obtained while nearly maintaining physical properties such as refractive anisotropy. By using the composition, a liquid crystal element having excellent reliability, capable of maintaining a high voltage retention until a high temperature region, is provided, and the display is very applicable as a VA type, ECB type, or IPS type liquid crystal display, and is particularly effective for speeding up response without thinning cell gaps.

Abstract: A nematic liquid crystal composition of the present invention includes 10 to 80% by mass of either one or at least two compounds represented by general formula (I) as a first component; and 20 to 70% by mass of either one or at least two compounds represented by general formula (II) as a second component, wherein a dielectric constant anisotropy is negative. The use of this nematic liquid crystal composition can provide a highly reliable liquid crystal display element capable of maintaining a high voltage-holding ratio even in a high temperature region, and achieving quick responsiveness without reducing the cell gap.

Abstract: An objective of the present invention is to provide compounds having Rho kinase inhibitory activity and useful for the treatment of diseases mediated by Rho kinase. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof: wherein Q represents phenyl, pyridyl, pyrrolyl, thienyl, or furyl; these groups are optionally substituted by one or two halogens or alkyl, nitro, or amino groups; and p is 2 or 3.

Abstract: A nematic liquid crystal composition of the present invention includes 10 to 80% by mass of either one or at least two compounds represented by general formula (I) as a first component; and 20 to 70% by mass of either one or at least two compounds represented by general formula (II) as a second component, wherein a dielectric constant anisotropy is negative. The use of this nematic liquid crystal composition can provide a highly reliable liquid crystal display element capable of maintaining a high voltage-holding ratio even in a high temperature region, and achieving quick responsiveness without reducing the cell gap.

Abstract: The present invention provides a liquid crystal composition having a negative dielectric anisotropy whose absolute value is large, and a low viscosity, and also provides a VA type liquid crystal element using the same. Disclosed is a liquid crystal composition containing a compound represented by the general formula (I) and an alkenyl compound represented by the general formula (II): By combining the liquid compounds according to the present invention, a liquid crystal composition having a low viscosity and a negative dielectric anisotropy could be obtained while nearly maintaining physical properties such as refractive anisotropy. By using the composition, a liquid crystal element having excellent reliability, capable of maintaining a high voltage retention until a high temperature region, is provided, and the display is very applicable as a VA type, ECB type, or IPS type liquid crystal display, and is particularly effective for speeding up response without thinning cell gaps.

Abstract: An objective of the present invention is to provide compounds having Rho kinase inhibitory activity. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof: Het—X—Z??(I) wherein Het represents a monocyclic or bicyclic heterocyclic group containing at least one nitrogen atom, for example, pyridyl or phthalimide; X represents group (i) —NH—C(?O)—NH—Q1-, group (ii) —NH—C(?O)—Q2-, wherein Q1 and Q2 represent a bond, alkylene, or alkenylene, or the like; and Z represents hydrogen, halogen, a monocyclic, bicyclic, or tricyclic carbocyclic group, a heterocyclic group or the like, for example, optionally substituted phenyl.

Abstract: An objective of the present invention is to provide compounds having Rho kinase inhibitory activity and useful for the treatment of diseases mediated by Rho kinase. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof: wherein Q represents phenyl, pyridyl, pyrrolyl, thienyl, or furyl; these groups are optionally substituted by one or two halogens or alkyl, nitro, or amino groups; and p is 2 or 3.

Abstract: Compounds having an Rho kinase inhibitory activity. These compounds include the compound of general formula (I): Het-X-Z, pharmaceutically acceptable salts thereof and solvates of the same, wherein Het represents a monocyclic or dicyclic heterocycle group containing at least one nitrogen atom (for example, pyridyl, phthalimido); X represents (i) an —NH—C(═O)—NH-Q1- group, (ii) an —NH—C(═O)-Q2- group, etc. (wherein Q1 and Q2 represent each a bond, alkylene or alkenylene); and Z represents hydrogen, halogeno, a monocyclic, dicyclic ortricyclic carbon cycle or heterocycle, etc. (for example, optionally substituted phenyl).